Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 406Neoplasms 367Prostatic Neoplasms 194Lung Neoplasms 185Colorectal Neoplasms 136Motor Activity 84Pancreatic Neoplasms 77Uterine Cervical Neoplasms 74Carcinoma, Non-Small-Cell Lung 72Head and Neck Neoplasms 67Brain Neoplasms 67Ovarian Neoplasms 59Carcinoma, Hepatocellular 50Neoplasm Metastasis 48Rectal Neoplasms 46Colonic Neoplasms 45Anxiety Disorders 45Precursor Cell Lymphoblastic Leukemia-Lymphoma 43Hematologic Neoplasms 39Depression 38Melanoma 36Glioblastoma 35Glioma 34Disease 34Multiple Myeloma 33Sarcoma 32Gastrointestinal Neoplasms 32Urinary Bladder Neoplasms 31Stomach Neoplasms 31Pain 31

Interventions

Speech Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Communication Disorders × 90 days × Clear all
NCT04969874 2026-05-12

E-CRIL_MAX

University Hospital, Toulouse

Phase NA Withdrawn

Communication Disorders

NCT05189366 2026-04-14

SOPHNEURO

Institut Cancerologie de l'Ouest

Phase NA Terminated
13 enrolled 8 charts
CNS

Communication Disorders, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡